Sleep Loss Delays Rat Surgical Recovery via Epigenetic Opioid Receptor Suppression

REM sleep disturbance downregulates the TET1 enzyme, reducing mu-opioid receptor expression in the spinal cord and dorsal root ganglion.

For Doctors in a Hurry

Researchers investigated how sleep deprivation delays surgical pain recovery by examining epigenetic changes in the dorsal root ganglion and spinal cord.
This study used rat models of plantar incision and sleep disturbance to analyze TET1 enzyme levels and mu-opioid receptor expression.
Sleep disturbance downregulated TET1 in lumbar regions, while restoring this enzyme prevented prolonged incisional pain and maintained opioid receptor levels.
The authors concluded that TET1 downregulation is required for sleep deprivation to delay recovery by reducing mu-opioid receptor expression in sensory neurons.
These findings suggest that epigenetic modulation of opioid receptors may explain why poor sleep quality worsens postoperative pain outcomes in patients.

The Epigenetic Link Between Sleep Architecture and Surgical Recovery

Postoperative sleep disturbance is a frequent complication that affects between 15 percent and 72 percent of surgical patients, often leading to impaired recovery and increased pain sensitivity [1]. Clinical evidence indicates a reciprocal relationship where poor sleep quality heightens acute pain intensity and increases the requirement for analgesic medications [2]. While pharmacological interventions such as dexmedetomidine or esketamine have been utilized to improve the pain-sleep interaction cycle, the underlying molecular drivers of this connection remain poorly understood [3, 4]. Addressing these disturbances is vital, as inadequate sleep is a modifiable risk factor that can significantly hinder the resolution of surgical trauma [5]. A recent study provides a detailed epigenetic explanation for how sleep loss directly alters the neural processing of pain, demonstrating that sleep deprivation actively suppresses the expression of opioid receptors in the spinal cord and peripheral nerves.

REM Sleep Disturbance and Spinal Gene Dysregulation

To investigate the molecular mechanisms by which sleep loss impairs postoperative healing, researchers utilized a rat model of plantar incision combined with short-term rapid eye movement (REM) sleep disturbance. This experimental design reflects the clinical reality that sleep disturbance delays surgical pain recovery, a phenomenon frequently observed in patients following major procedures. The study focused on gene dysregulation within two critical nodes of the somatosensory system: the dorsal root ganglion (the cluster of sensory nerve cell bodies) and the spinal dorsal horn (the region of the spinal cord that processes incoming pain signals). Specifically, the authors examined the expression of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), an enzyme involved in DNA demethylation, within these regions following the surgical incision.

The findings demonstrated that short-term REM sleep disturbance downregulated TET1 expression specifically in the ipsilateral L4 and L5 dorsal root ganglia and the spinal dorsal horn. This localized reduction in TET1 activity was directly associated with prolonged incisional pain in the rat model, suggesting that the enzyme plays a pivotal role in the resolution of postoperative hypersensitivity. The researchers identified that this impact is fundamentally linked to gene dysregulation in the dorsal root ganglion and spinal dorsal horn, where the loss of TET1 disrupts the normal epigenetic regulation required for pain recovery. By identifying that TET1 downregulation is a requirement for sleep disturbance to extend the duration of surgical pain, the study provides a specific molecular target for understanding why patients with fragmented sleep architecture experience more persistent postoperative discomfort.

Epigenetic Silencing of the Mu-Opioid Receptor

The molecular mechanism by which sleep loss impairs recovery centers on the Oprm1 promoter, the specific gene sequence that initiates the transcription of the mu-opioid receptor. The researchers assessed mu-opioid receptor (MOR) expression and the binding of the TET1 enzyme to this promoter region within the dorsal root ganglion and spinal dorsal horn. This process is governed by two critical epigenetic markers: 5-methylcytosine (5mC), a stable chemical mark that typically silences gene expression by inhibiting transcription, and 5-hydroxymethylcytosine (5hmC), a modified DNA base that serves as an indicator of active gene expression. The study measured these promoter-associated levels to determine how sleep disturbance alters the chemical landscape of DNA to suppress receptor production.

To confirm the role of this pathway, the authors utilized a herpes simplex virus vector to express Tet1 mRNA (HSV-TET1) in the affected neural tissues. The findings revealed that HSV-TET1 microinjection restored TET1 binding activity to the Oprm1 promoter and successfully restored 5hmC levels at the promoter site. Furthermore, this intervention reduced 5mC accumulation at the Oprm1 promoter, reversing the epigenetic silencing that occurs during sleep deprivation. By normalizing these markers, the researchers restored mu-opioid receptor expression in the L4 and L5 dorsal root ganglia and the spinal dorsal horn, which effectively prevented the prolongation of incisional pain induced by rapid eye movement sleep disturbance.

For the practicing clinician, these data provide a biological explanation for the reduced efficacy of opioid analgesics in sleep-deprived patients. The study demonstrates that the mechanism involves reducing mu-opioid receptor expression in the dorsal root ganglion and spinal dorsal horn, a direct consequence of TET1 downregulation. When sleep is fragmented, the resulting accumulation of 5mC and loss of 5hmC at the Oprm1 promoter creates a state of epigenetic suppression, leaving the patient with fewer functional receptors to modulate nociceptive signaling. This molecular shift suggests that postoperative sleep hygiene is not merely a matter of patient comfort, but a physiological requirement for maintaining the integrity of the endogenous opioid system and ensuring timely surgical recovery.

Restoration of TET1 Reverses Pain Hypersensitivity

To determine if the downregulation of the TET1 enzyme was the primary driver of delayed recovery, the researchers employed a viral vector to restore enzyme levels in the peripheral and central nervous systems. Specifically, a herpes simplex virus expressing Tet1 mRNA (HSV-TET1) was microinjected into the ipsilateral L4 and L5 dorsal root ganglia or the spinal dorsal horn. This targeted intervention allowed the authors to observe the effects of localized TET1 upregulation on the epigenetic landscape and subsequent pain behaviors in rats that had undergone plantar incision and rapid eye movement sleep disturbance.

The molecular analysis confirmed that the restoration of this enzyme successfully reversed the epigenetic silencing of opioid signaling. The HSV-TET1 microinjection restored mu-opioid receptor expression in the microinjected L4 and L5 dorsal root ganglia or spinal dorsal horn, effectively counteracting the receptor suppression caused by sleep loss. This restoration was accompanied by normalized levels of 5hmC, a marker of active gene transcription, and a reduction in the accumulation of 5mC, which typically silences gene expression. Most importantly for clinical outcomes, the HSV-TET1 microinjection prevented short-term rapid eye movement sleep disturbance-induced prolongation of incisional pain, allowing the nociceptive thresholds to return to baseline at a rate consistent with normal recovery.

These findings provide a clear mechanistic link between sleep quality and the physiological capacity for pain resolution. For the practicing clinician, this underscores that sleep deprivation does not just make patients more sensitive to pain through psychological fatigue, but rather induces a state of receptor-level resistance to both endogenous and exogenous opioids. The study demonstrates that the mechanism involves reducing mu-opioid receptor expression in the dorsal root ganglion and spinal dorsal horn, a process that can be entirely prevented by maintaining the activity of the TET1 enzyme. While viral gene therapy remains an experimental approach, these data suggest that protecting perioperative sleep architecture is a biological necessity to maintain the integrity of the opioid system and prevent the transition of acute surgical pain into a prolonged hypersensitive state.

Confirming the TET1-Opioid Axis

To validate that the loss of the TET1 enzyme is the specific driver of pain hypersensitivity, the researchers conducted loss-of-function experiments in naïve rats that had not undergone surgery or sleep deprivation. They utilized Tet1 small interfering RNA (siRNA) microinjection, a technique that uses short sequences of RNA to silence the expression of a specific gene, to mimic the effects of sleep loss. When this siRNA was microinjected into the L4 and L5 dorsal root ganglia or the spinal dorsal horn, it reduced mu-opioid receptor expression in those specific regions. This targeted molecular knockdown was sufficient to alter the animals' sensory thresholds, as the Tet1 siRNA microinjection induced nociceptive hypersensitivity, or an increased sensitivity to painful stimuli, in these otherwise healthy rats.

The researchers then sought to determine if the pain-inducing effects of TET1 depletion could be bypassed by directly restoring the opioid receptors. They found that the effects of Tet1 siRNA were abolished by co-microinjection of a lentivirus expressing Oprm1 mRNA (LV-MOR), a viral vector that provides the genetic instructions for the mu-opioid receptor. By providing the receptor directly, the researchers bypassed the need for the TET1 enzyme to keep the gene active. This rescue confirms that TET1 downregulation is required for short-term sleep disturbance to delay surgical pain recovery, as the absence of the enzyme leads directly to the loss of the receptors necessary for pain modulation.

For the practicing clinician, these findings emphasize that perioperative sleep is a biological requirement for maintaining the molecular machinery of pain control. Sleep loss triggers an epigenetic cascade that actively strips the nervous system of its primary targets for both endogenous and exogenous opioid signaling. This suggests that protecting sleep architecture is not merely a matter of patient comfort, but a necessary intervention to prevent the transition of acute surgical pain into a prolonged hypersensitive state by maintaining the integrity of the opioid system in the dorsal root ganglion and spinal dorsal horn.

Study Info

TET1 downregulation in the dorsal root ganglion and spinal cord is required for short-term sleep disturbance to delay surgical pain recovery

Jing Cao, Po‐Kai Wang, Bo Xu, Xiyao Gu, et al.

Journal British Journal of Anaesthesia

Published May 01, 2026